Dacarbazine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Dacarbazine. Educational only — not medical advice.

Labeled uses

Dacarbazine for Injection, USP is indicated in the treatment of metastatic malignant melanoma. In addition, dacarbazine is also indicated for Hodgkin's disease as a second-line therapy when used in combination with other effective agents.

Source: FDA labeling via NIH DailyMed (set 0d81315c…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.